University of Virginia — Charlottesville, Virginia

Public research footprint of University of Virginia, compiled from the ClinicalTrials.gov public registry.

2,655

Registered studies

785

Active

398

Recruiting now

1,334

Completed

342

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Lung Non-Small Cell Carcinoma · Recurrent Endometrial Carcinoma · Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT07232069 — PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis (Recruiting)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Virginia?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.